Intracanal dexamethasone is an emerging topic of interest in endodontics because of its potential to modulate inflammation and reduce post-instrumentation pain.
📌 Recommended Article :
Dental Article🔽 Updated Dexamethasone Management in Dentistry: Pharmacology, Clinical Applications, and Protocols ... This article reviews pharmacokinetics, pharmacodynamics, clinical indications, drug combinations, limitations, and updated evidence-based protocols.Unlike systemic corticosteroid therapy, local application aims to deliver an anti-inflammatory agent directly into the root canal system.
Advertisement
Dexamethasone has been investigated as an intracanal solution and as a component of calcium hydroxide-based medicaments. Related corticosteroid-containing pastes also provide a clinical context for understanding the potential benefits and limitations of local anti-inflammatory therapy.
However, these formulations are not interchangeable, and evidence supporting one preparation cannot automatically be extrapolated to another.
📌 Recommended Article :
Dental Article🔽 Zinc Oxide Eugenol vs Calcium Hydroxide–Iodoform in Pulpectomy ... The ideal obturation material should exhibit resorbability synchronized with root resorption, antimicrobial properties, and minimal toxicity to periapical tissues.✅ Why Use Dexamethasone as an Intracanal Medicament?
Dexamethasone is a potent glucocorticoid that suppresses inflammatory mediator production and modulates the host inflammatory response.
In endodontics, its proposed benefits include:
▪️ Reduction of postoperative pain associated with periapical inflammation.
▪️ Modulation of inflammatory responses following instrumentation.
▪️ Potential improvement in patient comfort during interappointment periods.
Importantly, dexamethasone is not an antimicrobial substitute for sodium hypochlorite irrigation, adequate chemomechanical preparation, or other established infection-control procedures.
📌 Recommended Article :
Dental Article🔽 Dexamethasone Side Effects in Dentistry: Clinical Risks Guide ... However, clinicians must be aware of its potential adverse effects, contraindications, and systemic implications, even when administered as a single dose.✅ Intracanal Dexamethasone: Solutions and Paste Formulations
Two approaches deserve particular attention: direct intracanal application of a corticosteroid solution and incorporation of dexamethasone into an intracanal paste.
| Formulation | Potential Purpose | Main Limitation |
|---|---|---|
| Intracanal dexamethasone solution | Potential local anti-inflammatory action and postoperative pain control. | Limited clinical evidence and variation in application protocols. |
| Calcium hydroxide–dexamethasone paste | Combines the intended antimicrobial action of calcium hydroxide with corticosteroid-mediated inflammation control. | Optimal formulation, compatibility, dosage, and clinical indications remain uncertain. |
| Corticosteroid–antibiotic paste | Combines anti-inflammatory activity with antimicrobial activity, depending on the ingredients. | Antibiotic-specific risks, potential discoloration, allergies, and antimicrobial stewardship concerns. |
Clinical note: Ledermix is a corticosteroid–antibiotic paste containing triamcinolone acetonide and demeclocycline, not dexamethasone. Evidence for one formulation should not be extrapolated directly to another.
✅ What Does the Clinical Evidence Show?
A randomized clinical trial by Ghanbarzadegan et al. (2019) evaluated intracanal medicaments in 90 necrotic molars and premolars. The investigators compared calcium hydroxide mixed with saline, calcium hydroxide mixed with 2% chlorhexidine, and calcium hydroxide mixed with dexamethasone.
The calcium hydroxide–dexamethasone group demonstrated lower pain scores than the calcium hydroxide–saline group during the first 24–72 hours. Differences were no longer statistically significant at 96 hours. These findings suggest a possible short-term analgesic benefit, but they do not establish universal superiority or define an optimal formulation.
A separate randomized trial published in 2024 investigated dexamethasone as a final intracanal rinse in patients with symptomatic irreversible pulpitis. The investigators reported better postoperative pain relief than with saline. However, this study evaluated a rinse, not a paste, and its findings should not be treated as direct evidence for sustained intracanal medication.
The broader evidence remains limited by differences in study design, patient selection, formulations, and outcome measurements. Intracanal dexamethasone is promising, but the evidence is insufficient to support routine use in every root canal treatment.
📌 Recommended Article :
Dental Article🔽 CTZ Paste in Primary Teeth Pulp Therapy: Indications, Benefits and Clinical Protocol ... The use of CTZ paste (Chloramphenicol–Tetracycline–Zinc Oxide) in primary teeth remains a topic of interest, especially in cases of infected primary molars where traditional pulpectomy is not feasible.✅ Safety and Clinical Limitations
Local administration does not eliminate the possibility of adverse effects. Relevant considerations include:
▪️ Potential local immunomodulation and effects on tissue healing.
▪️ Possible systemic exposure, depending on the preparation and amount used.
▪️ Formulation compatibility, stability, and removability.
▪️ The risk of suppressing inflammatory symptoms without adequately controlling infection.
When antibiotics are included in a paste, clinicians must also consider allergies, antimicrobial stewardship, and formulation-specific adverse effects.
Calcium hydroxide remains an established intracanal medicament when an interappointment dressing is indicated. Adding dexamethasone should not be assumed to improve disinfection or long-term healing without stronger comparative evidence.
📌 Recommended Article :
Dental Article🔽 Webinar: Behavior management in pediatric dentistry - Dr. Eyal Simchi ... Communication with parents and the pediatric patient is important. The dentist must transmit security and empathy, with the intention of reducing parental anxiety.💬 Discussion
The clinical interest in intracanal dexamethasone reflects an important distinction in endodontic pharmacology: controlling inflammation is not the same as controlling infection. A corticosteroid may reduce inflammatory symptoms, while successful treatment still depends on adequate microbial control and an effective coronal seal.
Combining dexamethasone with calcium hydroxide is scientifically interesting because the components have different intended functions. Nevertheless, the clinical performance of a combination depends on its formulation, concentration, chemical compatibility, and biological effects. Evidence from a small number of clinical trials cannot establish the safety or effectiveness of all compounded preparations.
The 2024 expert consensus on irrigation and intracanal medication emphasizes that intracanal medicaments are adjuncts to, rather than replacements for, thorough preparation and irrigation. Further randomized clinical trials should evaluate standardized formulations, adverse effects, postoperative pain, and long-term periapical healing.
✍️ Conclusion
Intracanal dexamethasone represents a potential adjunct for managing inflammation and postoperative pain in endodontics. Preliminary clinical evidence supports further investigation of calcium hydroxide–dexamethasone combinations and local corticosteroid application.
However, differences between solutions, compounded pastes, and commercially available corticosteroid–antibiotic preparations must be respected. Until stronger evidence establishes standardized protocols and long-term outcomes, intracanal dexamethasone should be regarded as a promising but insufficiently validated approach rather than a routine replacement for established endodontic medicaments.
🎯 Clinical Recommendations
▪️ Consider intracanal corticosteroid evidence critically and distinguish findings for dexamethasone from those for other glucocorticoids.
▪️ Do not assume that adding dexamethasone to calcium hydroxide improves antimicrobial efficacy or long-term healing.
▪️ Avoid unvalidated compounded formulations when compatibility, stability, dosage, and tissue safety have not been established.
▪️ Prioritize definitive infection control, appropriate case selection, and a durable coronal seal.
📚 References
✔ Ghanbarzadegan, A., Ajami, M., & Aminsobhani, M. (2019). The effect of different combinations of calcium hydroxide as intra-canal medicament on endodontic pain: A randomized clinical trial study. Iranian Endodontic Journal, 14(1), 1–6. https://doi.org/10.22037/iej.v14i1.22815
✔ Moskow, A., Morse, D. R., Krasner, P., & Furst, M. L. (1984). Intracanal use of a corticosteroid solution as an endodontic anodyne. Oral Surgery, Oral Medicine, and Oral Pathology, 58(5), 600–604. https://doi.org/10.1016/0030-4220(84)90086-0
✔ Negm, M. M. (2001). Intracanal use of a corticosteroid-antibiotic compound for the management of posttreatment endodontic pain. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics, 92(4), 435–439. https://doi.org/10.1067/moe.2001.115975
✔ Zou, X., Zheng, X., Liang, Y., Zhang, C., Fan, B., Liang, J., Ling, J., Bian, Z., Yu, Q., Hou, B., Chen, Z., Wei, X., Qiu, L., Chen, W., He, W., Xu, X., Meng, L., Chen, Z., Chen, L., ... Yue, L. (2024). Expert consensus on irrigation and intracanal medication in root canal therapy. International Journal of Oral Science, 16, Article 23. https://doi.org/10.1038/s41368-024-00280-5
📌 More Recommended Items
► Dexamethasone Dental Pain Protocols: Modern Guide
► Pulpectomy in Primary Teeth: Best Filling Materials (ZOE, Vitapex, and Metapex)
► Management of Pulpal Infections in Primary Teeth: Evidence-Based Protocols